Citation: Pg. Rose et al., PROLONGED ORAL ETOPOSIDE AS 2ND-LINE THERAPY FOR PLATINUM-RESISTANT AND PLATINUM-SENSITIVE OVARIAN-CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUPSTUDY, Journal of clinical oncology, 16(2), 1998, pp. 405-410
Authors:
MUGGIA FM
BLESSING JA
HOMESLEY HD
SOROSKY J
Citation: Fm. Muggia et al., TOMUDEX (ZD1694, NSC639186) IN PLATINUM-PRETREATED RECURRENT EPITHELIAL OVARIAN-CANCER - A PHASE-II STUDY BY THE GYNECOLOGIC-ONCOLOGY-GROUP, Cancer chemotherapy and pharmacology, 42(1), 1998, pp. 68-70
Citation: Hd. Homesley, SINGLE-AGENT THERAPY FOR NONMETASTATIC AND LOW-RISK GESTATIONAL TROPHOBLASTIC DISEASE, Journal of reproductive medicine, 43(1), 1998, pp. 69-74
Authors:
CREASMAN WT
ZAINO RJ
MAJOR FJ
DISAIA PJ
HATCH KD
HOMESLEY HD
Citation: Wt. Creasman et al., EARLY INVASIVE-CARCINOMA OF THE CERVIX (3 TO 5 MM INVASION) - RISK-FACTORS AND PROGNOSIS - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of obstetrics and gynecology, 178(1), 1998, pp. 62-65
Authors:
RANDALL ME
BARRETT RJ
SPIRTOS NM
CHALAS E
HOMESLEY HD
LENTZ SL
HANNA M
Citation: Me. Randall et al., CHEMOTHERAPY, EARLY SURGICAL REASSESSMENT, AND HYPERFRACTIONATED ABDOMINAL RADIOTHERAPY IN STAGE-III OVARIAN-CANCER - RESULTS OF A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, International journal of radiation oncology, biology, physics, 34(1), 1996, pp. 139-147
Authors:
MALFETANO JH
BLESSING JA
HOMESLEY HD
LOOK KY
MCGEHEE R
Citation: Jh. Malfetano et al., A PHASE-II TRIAL OF DIDEMNIN-B (NSC-NUMBER-335319) IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX A GYNECOLOGIC-ONCOLOGY-GROUP STUDY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 19(2), 1996, pp. 184-186
Authors:
REISINGER SA
ASBURY R
LIAO SY
HOMESLEY HD
Citation: Sa. Reisinger et al., A PHASE-I STUDY OF WEEKLY CISPLATIN AND WHOLE ABDOMINAL RADIATION FORTHE TREATMENT OF STAGE-III AND STAGE-IV ENDOMETRIAL CARCINOMA - A GYNECOLOGIC-ONCOLOGY-GROUP PILOT-STUDY, Gynecologic oncology, 63(3), 1996, pp. 299-303
Authors:
LOOK KY
BRUNETTO VL
CLARKEPEARSON DL
AVERETTE HE
MAJOR FJ
ALVAREZ RD
HOMESLEY HD
ZAINO RJ
Citation: Ky. Look et al., AN ANALYSIS OF CELL-TYPE IN PATIENTS WITH SURGICALLY STAGED STAGE IB CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 63(3), 1996, pp. 304-311
Authors:
KRIS MG
CUBEDDU LX
GRALLA RJ
CUPISSOL D
TYSON LB
VENKATRAMAN E
HOMESLEY HD
Citation: Mg. Kris et al., ARE MORE ANTIEMETIC TRIALS WITH A PLACEBO NECESSARY - REPORT OF PATIENT DATA FROM RANDOMIZED TRIALS OF PLACEBO ANTIEMETICS WITH CISPLATIN, Cancer, 78(10), 1996, pp. 2193-2198
Authors:
MCGUIRE WP
HOSKINS WJ
BRADY MF
HOMESLEY HD
CREASMAN WT
BERMAN ML
BALL H
BEREK JS
WOODWARD J
Citation: Wp. Mcguire et al., ASSESSMENT OF DOSE-INTENSIVE THERAPY IN SUBOPTIMALLY DEBULKED OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Journal of clinical oncology, 13(7), 1995, pp. 1589-1599
Authors:
GANDARA DR
NAHHAS WA
ADELSON MD
LICHTMAN SM
PODCZASKI ES
YANOVICH S
HOMESLEY HD
BRALY P
RITCH PS
WEISBERG SR
WILLIAMS L
DIASIO RB
PEREZ EA
KARP D
REICH SD
MCCARROLL K
HOFF JV
Citation: Dr. Gandara et al., RANDOMIZED PLACEBO-CONTROLLED MULTICENTER EVALUATION OF DIETHYLDITHIOCARBAMATE FOR CHEMOPROTECTION AGAINST CISPLATIN-INDUCED TOXICITIES, Journal of clinical oncology, 13(2), 1995, pp. 490-496
Citation: Jh. Malfetano et al., A PHASE-II TRIAL OF GALLIUM NITRATE (NSC NUMBER-15200) IN NONSQUAMOUSCELL-CARCINOMA OF THE CERVIX - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, American journal of clinical oncology, 18(6), 1995, pp. 495-497
Authors:
BRALY PS
BEREK JS
BLESSING JA
HOMESLEY HD
AVERETTE H
Citation: Ps. Braly et al., INTRAPERITONEAL ADMINISTRATION OF CISPLATIN AND 5-FLUOROURACIL IN RESIDUAL OVARIAN-CANCER - A PHASE-II GYNECOLOGIC-ONCOLOGY-GROUP TRIAL, Gynecologic oncology, 56(2), 1995, pp. 164-168
Authors:
SUTTON GP
BLESSING JA
HOMESLEY HD
MALFETANO JH
Citation: Gp. Sutton et al., A PHASE-II TRIAL OF IFOSFAMIDE AND MESNA IN PATIENTS WITH ADVANCED ORRECURRENT MIXED MESODERMAL TUMORS OF THE OVARY PREVIOUSLY TREATED WITH PLATINUM-BASED CHEMOTHERAPY - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY, Gynecologic oncology, 53(1), 1994, pp. 24-26
Citation: N. Kadar et al., PROGNOSTIC FACTORS IN SURGICAL STAGE-III AND STAGE-IV CARCINOMA OF THE ENDOMETRIUM, Obstetrics and gynecology, 84(6), 1994, pp. 983-986